Home» Circulars» Viewcirculars Back
 
OPPORTUNITY FOR ENTERING JAPANESE PHARMA MARKET/ Business partnership
 

PxlHeaderLogo

Ref: PXL/H.O./CIR-078/2015-16                         Date: 11.09.2015

 

OPPORTUNITY FOR ENTERING

JAPANESE PHARMA MARKET/ Business partnership

To
All the Members of Council,

 

Dear Sir/Madam,

In order to live up to the challenges of increasing market share in Japan and emerge as the most reliable partner to provide highly quality affordable generics to Japan, Pharmexcil with the support of Ministry of Commerce  developed a roadmap to engage with stakeholders' in Japan.

  

The efforts (click here for details) have resulted in creating awareness and warming up the local industry towards Indian companies. The sustained efforts need to be complimented with more participation from industry with a road map. In association with IBEF and under the active guidance of Ministry of Commerce the key elements of the road map of sustained programme in Japan is as follows:  

  • Developing critical mass of Indian companies over a period of three years who have potential to do business with Japanese companies.
  • Identifying companies in Japan for exploring opportunities for Indian companies in sourcing generics from India, make India as hub for generics manufacture , avail contract Manufacturing, R&D, technology transfers, Joint ventures and collaboration etc
  • Networking with Associations: MoUs could be signed with key associations like OPMA    (though the engagement with them is very strong), Japan Generic Manufacturers Association and others.
  • Engagement with Pharma clusters in various prefectures through Seminars/One-to-one meeting
  • Regulatory Exchange Programme: PMDA officials and DCGI to be brought close through seminars in India and Japan. This would also create more awareness on each others' regulatory framework.

In this direction, as s follow up earlier efforts, a small delegation under the leadership of Sri Sudhanshu Pandey  IAS , Joint Secretary (DoC), with Dr. V G Somani, Joint Drug Controller, CDSCO,  representatives of Industry and Pharmexcil  will be meeting top Japanese companies, Associations and PMDA for creating opportunities for India n companies during the period of 13-19th September 2015.

 

Pharmexcil members having  interest in Japanese Business association  on the above stated activities may like to send their complete profile along with necessary credentials to dg@pharmexcil.com and rd.aks@pharmexcil.com for taking up during the visit of high level delegation.

 

Looking forward to your kind participation to seize the opportunity and be a part of the sustained effort.

 

With best regards

 

Dr P V Appaji

Director General

H.O.: 101, Aditya Trade Centre, Ameerpet, Hyderbad-500038
Tel: +91-40-23735462/66, Fax: +91-40-23735464
Email: info@pharmexcil.com Website: www.pharmexcil.com